Capecitabine in combination with Oxaliplatin, Irinotecan and Bevacizumab (COI-B regimen) as First-Line therapy for metastatic colorectal cancer: a Phase II I.T.M.O. study.
收藏NIAID Data Ecosystem2026-03-06 收录
官方服务：
资源简介：
Primary Objectives Determine the efficacy in terms of : Response rate Safety profile of the COI regimen when administered with bevacizumab Safety profile of bevacizumab when administered after the end of chemotherapy
创建时间：
2009-04-15
